✦ LIBER ✦

Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies

✍ Scribed by Baluom, Muhammad (author);Grossbard, Elliott B. (author);Mant, Tim (author);Lau, David T.W. (author)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of fostamatinib, a sple

✍ Baluom, Muhammad (author);Grossbard, Elliott B. (author);Mant, Tim (author);Lau, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB

Phase I pharmacokinetic studies evaluati

✍ Aimee K. Bence; Eric B. Anderson; Maqbool A. Halepota; Michael A. Doukas; Philli 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 170 KB

Single- and multiple-dose pharmacokineti

✍ Xing Zeng; Yi Feng; Liu Yang; Yu Huang; Dan Zhou; Jing Sun; Yiming Liu; Yuanhui 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 852 KB

Pharmacokinetics of single and multiple

✍ H.C. Swaisland; R. Smith; H. Jones; J. Farebrother; A. Laight 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Safety, tolerability, and pharmacokineti

✍ H. Yamaya; K. Yoshida; J. Kuritani; J-i. Yonezawa; M. Tsuda; T. Shindo; S. Nagay 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

854 RESULTS OF A SAFETY, TOLERABILITY AN

✍ L. Proulx; B. Bourgault; N. Chauret; R. Larouche; M. Tanguay; R. Thibert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB